Scientists at the Indian Institute of Technology (BHU), Varanasi, have developed a promising light-activated approach to fighting bacterial infections. The technology uses specially designed chemical compounds that become active under green light, offering a potential new direction for infected wound treatment and research into antimicrobial resistance.
1. How the Green-Light Technology Works
The research team developed three osmium-based compounds called metallophotoantibiotics. When exposed to green light, these compounds generate reactive oxygen species, which can damage bacterial cells and interfere with their biological processes.
2. Three Compounds Put to the Test
Researchers evaluated the compounds, identified as Os1, Os2 and Os3, against three bacterial species: E. coli, Staphylococcus aureus and Bacillus subtilis. Among the candidates, Os1 showed particularly promising antibacterial activity when activated by green light.
3. Tackling Protective Bacterial Biofilms
Biofilms are protective communities of bacteria that can form on surfaces, including medical devices and wounds. They can make infections more difficult to manage.
In laboratory experiments, Os1 combined with green light reduced biofilm formation by approximately 85% for E. coli and B. subtilis. Researchers also reported activity against already established biofilms, an important area for further investigation.
4. Promising Results in Wound-Healing Studies
The team also tested the treatment in animals with bacteria-infected wounds. Reports on the research described approximately 99% wound healing by day 11 following treatment with Os1 and green light.
These findings are encouraging, but animal-study results do not establish that the technology will work equally well or safely in people.
5. Why the Research Matters
Antimicrobial resistance makes some bacterial infections increasingly difficult to treat with existing medicines. A light-activated approach could eventually offer an additional way to target bacteria, particularly in situations where treatment can be directed towards an infected area.
However, the technology has not yet been established as a replacement for standard antibiotics or routine wound care.
6. The Scientists Behind the Discovery
The research brought together teams led by Dr Samya Banerjee from IIT (BHU)’s Department of Chemistry and Dr Sudip Mukherjee from its School of Biomedical Engineering. Their work was published in Communications Chemistry, a journal in the Nature Portfolio.
7. What Happens Next?
Further studies will be needed to establish the compounds’ safety, effectiveness against drug-resistant bacteria and suitability for human treatment. Researchers will also need to investigate potential side effects and determine how the technology could be delivered in clinical settings.
For now, the findings represent a promising step in exploring how light-responsive chemistry could contribute to future approaches to bacterial infections and wound healing.
